Antioxidant Vitamins and the Prevention of Cardiovascular Disease
Cardiovascular disease is caused by
One promising constituent is a famous group of substances known as antioxidants. The two antioxidants that have received the most attention are
However, a new analysis of randomized clinical trials, published in the June 14, 2003 issue of
, suggests that the routine use of antioxidents not only fails to significantly reduce the risk of cardiovascular death or
About the study
The researchers conducted a thorough search of the medical literature to identify all of the randomized controlled trials involving the use of antioxidant vitamins for the prevention of cardiovascular disease or its complications. For beta-carotene, the researchers identified 12 trials in total, eight of which involved individuals without known CVD (primary prevention) and four of which involved patients with CVD (secondary prevention). For vitamin E, seven trials were identified, the majority of which were secondary prevention trials. All of the trials were large, involving at least 1,000 patients.
The vitamin E trials involved a combined total of 81,788 patients and the beta-carotene trials involved a combined total of 138,113 patients. The researchers found that vitamin E did not significantly lower the risk for cardiovascular death or stroke compared with placebo (11.3% versus 11.1% respectively). The researchers also found that beta carotene actually led to a small, but significant increase in mortality from any cause (7.4% versus 7.0% respectively) and a slight (but statistically non-significant) increase in the risk of cardiovascular death.
How does this affect you?
The researchers concluded that neither supplement is effective for the prevention of cardiovascular disease or its complications, and that some patients receiving the beta-carotene supplement may have actually increased their risk of CVD. Therefore, the researchers determined that they could not support the routine use of vitamin E supplements for the prevention of CVD.
The researchers also stated that they could not support supplementation with beta-carotene under any circumstances. While this view is unlikely to be shared by many of their colleagues, the researchers went on to recommend that the use of vitamin supplements containing beta-carotene be actively discouraged, and that all clinical studies involving beta-carotene be discontinued due to its potential health risks to the participants.
The researchers concede, however that there are some important limitations to their study. For example, the small negative health effect noted for beta-carotene was driven by two studies in which the patients were at high risk for lung cancer, and past studies have shown that high doses of beta-carotene in smokers can indeed increase their risk for heart disease and stroke.
In addition, some researchers believe that antioxidants are more effective in inhibiting the early stages of atherosclerosis (plaque formation) than in preventing symptoms in the later stages of the disease. Therefore, the researchers concede that further study of the effects of vitamin E in primary prevention studies may be warranted.
It is important to note that all of the trials in the meta-analysis were conducted using vitamin supplements. Antioxidant rich foods may provide other beneficial nutrients such as flavonoids and
The initial enthusiasm for antioxidant supplementation was based largely on observational studies. The recent publication of numerous controls trials, however, has raised many doubts about their beneficial health effects. As we watch yet another magic bullet go bust we must face, once again, the unsurprising truth that diet and exercise are the only real weapons we have in the battle against too much food and too much fat.
The American Heart Association
Antioxidant consumption and risk of coronary heart disease. American Heart Association.
Available at: http://www.americanheart.org/presenter.jhtml?identifier=2062
Accessed June 18, 2003.
Vivekananthan DP, Penn MS, Sapp SK et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomized trials. Lancet. 2003;361:2017-2023.
Last reviewed June 20, 2003 by
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2007 EBSCO Publishing All rights reserved.